Search

Your search keyword '"Salmela, Kaija"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Salmela, Kaija" Remove constraint Author: "Salmela, Kaija" Topic kidney transplantation Remove constraint Topic: kidney transplantation
45 results on '"Salmela, Kaija"'

Search Results

1. Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation.

2. Pretransplant dialysis duration and risk of death after kidney transplantation in the current era.

3. Serum neutrophil gelatinase-associated lipocalin and recovery of kidney graft function after transplantation.

4. Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction.

5. [Kidney transplantation from a living donor: criteria for donor and recipient].

6. BK virus viremia in a well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression.

7. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.

8. HHV-6B is frequently found in the gastrointestinal tract in kidney transplantation patients.

9. Posttransplant sCD30 as a predictor of kidney graft outcome.

10. Donor risk score and baseline biopsy CADI value predict kidney graft outcome.

11. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study.

12. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation.

13. Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.

14. [Kidney transplantation criteria in Finland].

15. CMV findings in the gastrointestinal tract in kidney transplantation patients, patients with end-stage kidney disease and immunocompetent patients.

16. Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation.

17. Head and neck cancer in renal transplant patients in Finland.

18. Intragraft coagulation events and delayed graft function in clinical renal transplantation.

19. Lack of association between thrombosis-associated and cytokine candidate gene polymorphisms and acute rejection or vascular complications after kidney transplantation.

20. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety.

21. Current challenges in renal transplantation from deceased donors.

22. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.

23. The impact of donor cytokine gene polymorphisms on the incidence of cytomegalovirus infection after kidney transplantation.

24. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.

25. Rapid progression of small cell carcinoma in a renal transplant recipient.

26. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.

27. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.

28. Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations.

29. Activated protein C reduces graft neutrophil activation in clinical renal transplantation.

30. Gastroduodenal cytomegalovirus infection is common in kidney transplantation patients.

31. Predictors of renal allograft histologic damage progression.

32. [Is tissue typing is unnecessary for kidney transplantation?].

33. Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial.

34. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation.

35. Severe gastrointestinal complications after 1,515 adult kidney transplantations.

36. Why do some diabetic patients on the kidney transplant waiting list not receive a transplant?

37. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.

38. Association of graft neutrophil sequestration with delayed graft function in clinical renal transplantation.

39. Application of human leukocyte antigen matching in the allocation of kidneys from cadaveric organ donors in the Nordic countries.

40. [Organ transplants, relevant operations already for 40 years].

41. Ascorbic acid against reperfusion injury in human renal transplantation.

42. Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.

43. Should Helicobacter pylori infection be treated before kidney transplantation?

44. Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients.

45. Bacteremia among Kidney Transplant Recipients: a Case-control Study of Risk Factors and Short-term Outcomes.

Catalog

Books, media, physical & digital resources